Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

Frequent losses of chromosome 19p have recently been observed in sporadic lung adenocarcinomas, targeting the location of a critical tumor suppressor gene. Here we performed fine mapping of the short arm of chromosome 19 and found that the LKB1/STK11 gene mapped in the minimal-deleted region. Because germ-line mutations at LKB1/STK11 result in the Peutz-Jeghers syndrome and an increased risk of cancer, we performed a detailed genetic screen of the LKB1/STK11 gene in lung tumors. We detected a high frequency of somatic alterations (mainly nonsense mutations) in primary lung adenocarcinomas and in lung cancer cell lines. Thus, our findings demonstrate for the first time that LKB1/STK11 inactivation is a very common event and may be integrally involved in the development of sporadic lung adenocarcinoma.

[1]  J. Nezu,et al.  Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase , 1998, Nature Genetics.

[2]  V. McKusick,et al.  Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. , 1949, The New England journal of medicine.

[3]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[4]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Kathleen R. Cho,et al.  Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.

[6]  A J Krush,et al.  Increased risk of cancer in the Peutz-Jeghers syndrome. , 1987, The New England journal of medicine.

[7]  K. Alitalo,et al.  Vascular Abnormalities and Deregulation of VEGF in Lkb1-Deficient Mice , 2001, Science.

[8]  S. Steinberg,et al.  Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. , 1995, Journal of the National Cancer Institute.

[9]  T. Mäkelä,et al.  Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Y. Nakamura,et al.  Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. , 1994, Cancer research.

[11]  J. Osinga,et al.  Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer , 1987, Nature.

[12]  A. Ashworth,et al.  The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. , 1999, Human molecular genetics.

[13]  P L Pearson,et al.  Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. , 1991, Oncogene.

[14]  J. Maller,et al.  Cloning and Characterization of a Novel Serine/Threonine Protein Kinase Expressed in Early Xenopus Embryos* , 1996, The Journal of Biological Chemistry.

[15]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[16]  D. Morton,et al.  The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. , 2000, Development.

[17]  J. Jen,et al.  Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. D. Edwards,et al.  Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. , 1995, Cancer research.

[19]  J. Herman,et al.  Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer , 1999, Oncogene.

[20]  L. Cantley,et al.  The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. , 2001, Molecular cell.

[21]  S. Piantadosi,et al.  Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. , 2001, Cancer research.

[22]  L. Aaltonen,et al.  Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. , 1998, Cancer research.

[23]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[24]  D. Sidransky,et al.  Rates of p16 (MTS1) mutations in primary tumors with 9p loss. , 1994, Science.

[25]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  F. Kanai,et al.  LKB1 Associates with Brg1 and Is Necessary for Brg1-induced Growth Arrest* , 2001, The Journal of Biological Chemistry.

[27]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[28]  J. Herman,et al.  Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome , 2000, Oncogene.

[29]  J. Minna,et al.  Progress in understanding the molecular pathogenesis of human lung cancer. , 1998, Biochimica et biophysica acta.

[30]  J. Minna,et al.  Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types , 1998, Genes, chromosomes & cancer.

[31]  R. Hruban,et al.  Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. , 1994, Cancer research.

[32]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[33]  L. Aaltonen,et al.  LKB1 somatic mutations in sporadic tumors. , 1999, The American journal of pathology.